Titan Biotech Stock

Titan Biotech P/B

The P/B (Price-to-Book Ratio) of Titan Biotech (524717.BO) as of Aug 14, 2026 is 9.94. In the previous year, P/B (Price-to-Book Ratio) was 11.43 — a change of -13.01% (lower).

P/B

9.94

YoY

-13.01%

Last updated:

P/B (Price-to-Book Ratio) of Titan Biotech is 2026 9.94 . P/B (Price-to-Book Ratio) of Titan Biotech was 2025 11.43 . It decreases by -13.01% lower compared to the previous year.
Access this data via the Eulerpool API

Titan Biotech Stock analysis

What does Titan Biotech do? Titan Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Titan Biotech stock

P/B (Price-to-Book Ratio) of Titan Biotech is 9.94 in 2026.

P/B (Price-to-Book Ratio) of Titan Biotech changed from 11.43 to 9.94, representing a -13.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Titan Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Titan Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Titan Biotech

All Key Metrics — Titan Biotech